Therapeutic Focus

Overview

Oculis’ strategy is to employ its platform technology to develop eye drop products that have improved properties over approved drugs and address unmet medical needs in large, established markets. Based on this approach, Oculis has created a portfolio of product candidates, including treatment for DME, posterior/intermediate uveitis, dry-eyes, glaucoma and diabetic retinopathy. Oculis research also covers other therapeutic areas, including non-ocular applications benefitting from the Oculis technique.

For further information, contact us at info@oculispharma.com.